AtriCure (ATRC) Cash from Financing Activities (2010 - 2026)

AtriCure (ATRC) has 17 years of Cash from Financing Activities data on file, last reported at -$13.3 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 28.38% year-over-year to -$13.3 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 71.08% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 132.64% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$13.3 million, down from $2.1 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for ATRC reached as high as $6.0 million in Q3 2025 and fell as low as -$13.3 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged -$1.3 million across 5 years, with a median of $1.7 million in 2024.
• Across the five-year window, Cash from Financing Activities slumped 352.27% in 2024 and jumped 1897.0% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $2.0 million in 2022, then gained by 19.02% to $2.4 million in 2023, then decreased by 26.32% to $1.7 million in 2024, then rose by 20.71% to $2.1 million in 2025, then tumbled by 731.79% to -$13.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$13.3 million in Q1 2026, $2.1 million in Q4 2025, and $6.0 million in Q3 2025.